TP53 and cancer: Our results provide new insight into the crosstalk between GOF p53 mutations and LPA signaling in cancer progression, and indicate that downregulation of ACP6 expression is an early event in HGSOC development, with loss of ACP6 expression observed in in situ ovarian cancer.